209 related articles for article (PubMed ID: 20738882)
41. Virological self-sampling to monitor influenza antiviral susceptibility in a community cohort.
Lackenby A; Elliot AJ; Powers C; Andrews N; Ellis J; Bermingham A; Thompson C; Galiano M; Large S; Durnall H; Fleming D; Smith G; Zambon M
J Antimicrob Chemother; 2013 Oct; 68(10):2324-31. PubMed ID: 23759670
[TBL] [Abstract][Full Text] [Related]
42. High-resolution melting approach to efficient identification and quantification of H275Y mutant influenza H1N1/2009 virus in mixed-virus-population samples.
Lee HK; Lee CK; Loh TP; Tang JW; Tambyah PA; Koay ES
J Clin Microbiol; 2011 Oct; 49(10):3555-9. PubMed ID: 21865430
[TBL] [Abstract][Full Text] [Related]
43. A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses.
Deng YM; Caldwell N; Hurt A; Shaw T; Kelso A; Chidlow G; Williams S; Smith D; Barr I
Antiviral Res; 2011 Apr; 90(1):87-91. PubMed ID: 21376084
[TBL] [Abstract][Full Text] [Related]
44. Characterization of oseltamivir-resistant influenza virus populations in immunosuppressed patients using digital-droplet PCR: Comparison with qPCR and next generation sequencing analysis.
Pichon M; Gaymard A; Josset L; Valette M; Millat G; Lina B; Escuret V
Antiviral Res; 2017 Sep; 145():160-167. PubMed ID: 28780426
[TBL] [Abstract][Full Text] [Related]
45. Neuraminidase H275Y and hemagglutinin D222G mutations in a fatal case of 2009 pandemic influenza A (H1N1) virus infection.
DeVries A; Wotton J; Lees C; Boxrud D; Uyeki T; Lynfield R
Influenza Other Respir Viruses; 2012 Nov; 6(6):e85-8. PubMed ID: 22243670
[TBL] [Abstract][Full Text] [Related]
46. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
[TBL] [Abstract][Full Text] [Related]
47. Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007-2008 season.
Ciblak MA; Hasoksuz M; Escuret V; Valette M; Gul F; Yilmaz H; Turan N; Bozkaya E; Badur S
J Med Virol; 2009 Sep; 81(9):1645-51. PubMed ID: 19626608
[TBL] [Abstract][Full Text] [Related]
48. Rapid detection of the S247N neuraminidase mutation in influenza A(H1N1)pdm09 virus by one-step duplex RT-PCR assay.
Takayama I; Nakauchi M; Fujisaki S; Odagiri T; Tashiro M; Kageyama T
J Virol Methods; 2013 Mar; 188(1-2):73-5. PubMed ID: 23261798
[TBL] [Abstract][Full Text] [Related]
49. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
Hurt AC; Ernest J; Deng YM; Iannello P; Besselaar TG; Birch C; Buchy P; Chittaganpitch M; Chiu SC; Dwyer D; Guigon A; Harrower B; Kei IP; Kok T; Lin C; McPhie K; Mohd A; Olveda R; Panayotou T; Rawlinson W; Scott L; Smith D; D'Souza H; Komadina N; Shaw R; Kelso A; Barr IG
Antiviral Res; 2009 Jul; 83(1):90-3. PubMed ID: 19501261
[TBL] [Abstract][Full Text] [Related]
50. Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis.
Redlberger-Fritz M; Aberle SW; Strassl R; Popow-Kraupp T
Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1593-601. PubMed ID: 22089329
[TBL] [Abstract][Full Text] [Related]
51. Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.
Couturier BA; Bender JM; Schwarz MA; Pavia AT; Hanson KE; She RC
Influenza Other Respir Viruses; 2010 Jul; 4(4):199-204. PubMed ID: 20836794
[TBL] [Abstract][Full Text] [Related]
52. Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus.
Pokorná J; Pachl P; Karlukova E; Hejdánek J; Řezáčová P; Machara A; Hudlický J; Konvalinka J; Kožíšek M
Viruses; 2018 Jun; 10(7):. PubMed ID: 29933553
[TBL] [Abstract][Full Text] [Related]
53. Spread of Influenza A(H1N1) oseltamivir-resistant viruses in Africa in 2008 confirmed by multiple introductions in Senegal.
Dia N; Niang MN; Diadhiou SA; Goudiaby DG; Faye A; Kiori D; Bâ M; Michel R; Diop OM
BMC Infect Dis; 2013 Feb; 13():106. PubMed ID: 23442314
[TBL] [Abstract][Full Text] [Related]
54. Rapid genotypic assay for detection of oseltamivir-resistant influenza A (H1N1) viruses.
Hata M; Tanaka S; Yasui Y; Fujiwara N; Kobayashi S; Minagawa H
J Clin Microbiol; 2010 May; 48(5):1983-4. PubMed ID: 20220172
[No Abstract] [Full Text] [Related]
55. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
[TBL] [Abstract][Full Text] [Related]
56. Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada.
Longtin J; Patel S; Eshaghi A; Lombos E; Higgins R; Alexander D; Olsha R; Doyle J; Tran D; Sarabia A; Lee C; Bastien N; Li Y; Low D; Boivin G; Gubbay J
J Clin Virol; 2011 Mar; 50(3):257-61. PubMed ID: 21251873
[TBL] [Abstract][Full Text] [Related]
57. Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis.
Duan S; Boltz DA; Li J; Oshansky CM; Marjuki H; Barman S; Webby RJ; Webster RG; Govorkova EA
Antimicrob Agents Chemother; 2011 Oct; 55(10):4718-27. PubMed ID: 21730113
[TBL] [Abstract][Full Text] [Related]
58. Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
Saito R; Sato I; Suzuki Y; Baranovich T; Matsuda R; Ishitani N; Dapat C; Dapat IC; Zaraket H; Oguma T; Suzuki H
Pediatr Infect Dis J; 2010 Oct; 29(10):898-904. PubMed ID: 20442686
[TBL] [Abstract][Full Text] [Related]
59. Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009.
Casalegno JS; Bouscambert-Duchamp M; Caro V; Schuffenecker I; Sabatier M; Traversier A; Valette M; Lina B; Ferraris O; Escuret V
Antiviral Res; 2010 Aug; 87(2):242-8. PubMed ID: 20665943
[TBL] [Abstract][Full Text] [Related]
60. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
Correia V; Santos LA; Gíria M; Almeida-Santos MM; Rebelo-de-Andrade H
J Med Virol; 2015 Jan; 87(1):45-56. PubMed ID: 25042157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
